DnaAcos is a privately-owned biopharmaceutical company; the Norwegian Radium Hospital Research Foundation being the largest investor.  The company has received development grants from the Norwegian Research Council. The company will fund further development of its pipeline through a combination of own and external funding, licensing revenues and collaboration.

For further information, contact:
Jónas Einarsson, Chairman of the Board
je@radforsk.noThis email address is being protected from spam bots, you need Javascript enabled to view it
Tel. +47 48096355